D'Cruz D P, Wisnieski J J, Asherson R A, Khamashta M A, Hughes G R
Lupus Arthritis Research Unit, Rayne Institute, St. Thomas' Hospital, London, UK.
J Rheumatol. 1995 Sep;22(9):1669-73.
Urticarial vasculitis (UV) is both a primary disorder and a cutaneous vasculitic manifestation in patients with connective tissue diseases. We examined the prevalence of autoantibodies to vascular endothelial cells (aECA) and anti-Clq antibodies in patients with UV.
ELISA were used to detect aECA and anti-Clq autoantibodies, and we tested for correlation with UV in 4 patient groups: healthy controls, patients with systemic lupus erythematosus (SLE) with and without UV, patients with primary systemic vasculitides with UV, and patients with hypocomplementemic urticarial vasculitis syndrome (HUVS).
aECA were detected in 82% of patients with SLE with UV and 70% of patients with HUVS. In contrast, aECA were found in 32% of patients with SLE without UV and 14% of patients with primary UV. Anti-Clq antibodies were present in all patients with HUVS, but in < 20% in the other 3 groups. Antineutrophil cytoplasmic antibodies were detected in only one patient.
Although the development of UV is likely to be multifactorial, the high prevalence of aECA in HUVS and SLE with UV suggests that this antibody is associated with vasculitis and may have a role in the pathogenesis of UV in these patients.
荨麻疹性血管炎(UV)既是一种原发性疾病,也是结缔组织病患者的皮肤血管炎表现。我们检测了UV患者中血管内皮细胞自身抗体(aECA)和抗C1q抗体的患病率。
采用酶联免疫吸附测定法(ELISA)检测aECA和抗C1q自身抗体,并在4组患者中测试其与UV的相关性:健康对照者、有或无UV的系统性红斑狼疮(SLE)患者、有UV的原发性系统性血管炎患者以及低补体血症性荨麻疹性血管炎综合征(HUVS)患者。
在有UV的SLE患者中,82%检测到aECA,在HUVS患者中,70%检测到aECA。相比之下,在无UV的SLE患者中,32%检测到aECA,在原发性UV患者中,14%检测到aECA。所有HUVS患者均存在抗C1q抗体,但在其他3组中,该抗体的存在率<20%。仅在1例患者中检测到抗中性粒细胞胞浆抗体。
虽然UV的发病可能是多因素的,但aECA在HUVS和有UV的SLE患者中的高患病率表明,这种抗体与血管炎相关,可能在这些患者UV的发病机制中起作用。